Contents
Special Issue Topic

Exploring Type 2 Diabetes Mellitus

Guest Editors

Dr. Alessandro Mantovani E-Mail

Assistant Professor, Section of Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy

Research Keywords: Type 2 diabetes and risk of cardiovascular complications, type 2 diabetes and risk of diabetic foot complications

Dr. Giovanni Targher E-Mail

Associate Professor, Section of Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy

Research Keywords: Type 2 diabetes and risk of chronic vascular complications of diabetes, role of nonalcoholic fatty liver disease in diabetes

About the Special lssue

Type 2 diabetes mellitus is a major public health problem that has reached epidemic proportions worldwide. Type 2 diabetes mellitus is also strongly associated with serious chronic complications, including ischemic heart disease, stroke, blindness, kidney disease and lower-extremity amputations leading to disability and early mortality. From 1980 to 2014, the number of people affected by type 2 diabetes mellitus almost quadrupled from 108 million to 422 million worldwide, showing a growth in the global prevalence from 4.7% to 8.5%. This growth trend is not estimated to slow in the near future. Indeed, according to the recent estimates from the International Diabetes Federation, the prevalence of the disease is expected to further increase to 9.9% by the year 2045 with an estimated population of around 640 million people with diabetes worldwide. This undoubtedly represents a potential future healthcare crisis for patients and providers alike. Areas of ongoing research include all aspects of type 2 diabetes mellitus, including epidemiology, physiopathology, risk factors, complications, management and treatment.

Keywords: Type 2 diabetes, chronic complications, epidemiology, management, pharmacologic treatment, risk factors

Published Articles

Open Access Original Article
Risk factors in acute diabetic foot syndrome: analysis of 75 consecutive patients referred to a tertiary center in Modena, Italy
Mauro Maurantonio ... Luca Roncucci
Published: February 28, 2021 Explor Med. 2021;2:98–109
3079 32 0
Open Access Review
Silent coronary artery disease in type 2 diabetes: a narrative review on epidemiology, risk factors, and clinical studies
Saula Vigili de Kreutzenberg
Published: February 28, 2021 Explor Med. 2021;2:1–19
4572 83 1
Open Access Review
The entero-insular axis: a journey in the physiopathology of diabetes
Roberta Malaguarnera ... Salvatore Piro
Published: December 31, 2020 Explor Med. 2020;1:364–376
4074 79 1
Open Access Review
Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?
Erika Pedone ... Amelia Caretto
Published: October 30, 2020 Explor Med. 2020;1:314–330
5982 72 2
Open Access Review
Type 2 diabetes and cancer: problems and suggestions for best patient management
Agostino Milluzzo ... Laura Sciacca
Published: August 31, 2020 Explor Med. 2020;1:184–204
9419 177 13
Open Access Meta-Analysis
GLP-1 receptor agonists for NAFLD treatment in patients with and without type 2 diabetes: an updated meta-analysis
Alessandro Mantovani ... Giovanni Targher
Published: June 29, 2020 Explor Med. 2020;1:108–123
4313 100 4